CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions		Total	Issued common stock	Common stock held in treasury	Common stock held in treasury Restricted Stock	Capital in excess of par value	Retained earnings	Accumulated other comprehensive income (loss)	Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2019			246,387,057
Beginning balance, common stock held in treasury (in shares) at Dec. 31, 2019				39,979,514
Beginning balance at Dec. 31, 2019			$ 3	$ (1,657)		$ 1,145	$ 5,942	$ (727)	$ 138
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared	[1]						(146)		(22)
Noncontrolling interest contributions									4
Acquisition of delphi technologies (in shares)			37,188,819	197,811
Acquisition of Delphi Technologies						1,477			89
Net issuance for executive stock plan (in shares)				297,108
Net issuance for executive stock plan				$ 12		(8)
Net issuance of restricted stock (in shares)					595,052
Net issuance of restricted stock					$ 27
Purchases of treasury stock (shares)				(5,755,630)
Purchase of treasury stock				$ (216)
Net earnings		$ 500					500		67
Other comprehensive income (loss)		76						76
Comprehensive income		$ 663							20
Ending balance (in shares) at Dec. 31, 2020			283,575,876
Ending Balance, common stock held in treasury (in shares) at Dec. 31, 2020				44,645,173
Ending balance at Dec. 31, 2020			$ 3	$ (1,834)		2,614	6,296	(651)	296
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, dividends, declared (in dollars per share)		$ 0.68
Dividends declared	[1]						(162)		(84)
Net issuance for executive stock plan (in shares)				89,787
Net issuance for executive stock plan				$ 2		19
Net issuance of restricted stock (in shares)					756,402
Net issuance of restricted stock					$ 20	5
Acquisition of AKASOL									96
Purchase/sale of noncontrolling interest						(1)			(90)
Net earnings		$ 537					537		102
Other comprehensive income (loss)		100						100
Comprehensive income		$ 733							(6)
Ending balance (in shares) at Dec. 31, 2021		283,575,876	283,575,876
Ending Balance, common stock held in treasury (in shares) at Dec. 31, 2021		43,798,984		43,798,984
Ending balance at Dec. 31, 2021		$ 7,262	$ 3	$ (1,812)		2,637	6,671	(551)	314
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, dividends, declared (in dollars per share)		$ 0.68
Dividends declared	[1]						(161)		(85)
Net issuance for executive stock plan (in shares)				181,212
Net issuance for executive stock plan				$ 4		28
Net issuance of restricted stock (in shares)					583,021
Net issuance of restricted stock					$ 16	9
Purchases of treasury stock (shares)				(6,418,914)
Purchase of treasury stock				$ (240)
Purchase/sale of noncontrolling interest						1			(3)
Net earnings		$ 944					944		82
Other comprehensive income (loss)		(325)						(325)
Comprehensive income		$ 677							(24)
Ending balance (in shares) at Dec. 31, 2022		283,575,876	283,575,876
Ending Balance, common stock held in treasury (in shares) at Dec. 31, 2022		49,453,665		49,453,665
Ending balance at Dec. 31, 2022		$ 7,508	$ 3	$ (2,032)		$ 2,675	$ 7,454	$ (876)	$ 284
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, dividends, declared (in dollars per share)		$ 0.68

[1] Dividends declared relate to BorgWarner common stock.